Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 1;26(10):986-988.
doi: 10.5588/ijtld.22.0264.

Pediatric delamanid treatment for children with rifampicin-resistant TB

Affiliations

Pediatric delamanid treatment for children with rifampicin-resistant TB

N Tyeku et al. Int J Tuberc Lung Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared.

References

    1. Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. Lancet. 2019;294:967–978. - PubMed
    1. Chiang SS, et al. Barriers to the diagnosis of childhood tuberculosis: a qualitative study. Int J Tuberc Lung Dis. 2015;19(10):1144–1152. - PubMed
    1. Lopez-Varela E, et al. Treatment outcomes and safety in children with rifampicin-resistant tuberculosis. Int J Tuberc Lung Dis. 2022;26(2):133–141. - PubMed
    1. Das M, et al. Challenging drug resistant TB treatment journey for children, adolescents and their care-givers: a qualitative study. PLoS One. 2021;16(3):e0248408. - PMC - PubMed
    1. Furin J, et al. A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2015;19(Suppl 1):55–60. - PubMed

MeSH terms

LinkOut - more resources